Luis Ramos Harvard Medical School BIDMC Department of Radiology Class of 2011
|
|
- Reynold Weaver
- 5 years ago
- Views:
Transcription
1 1 Luis Ramos Harvard Medical School BIDMC Department of Radiology Class of 2011
2 Index Case Relevant Anatomy Basic Facts of Prostate Cancer Menu of Radiologic Tests for the Evaluation and Diagnosis Role of Radical Prostatectomy Discussion of Urinary Incontinence Conclusion
3 CC: Elevated PSA HPI: Mr. SR is a 67 year old male s/p standard radical prostatectomy, s/p salvage radiotherapy one yr later that presents with a rising PSA from 2.4 to 3.7. Pt has been complaining of urinary incontinence, as he wears 4 diapers a day. ROS: Not significant for bone pain, back pain, dysuria, urinary frequency PMH: HTN Hypercholesterolemia Leiomyoma in Gastric esophageal junction Allergies: Penicillin MEDS: Allegra, Hctz, Simvastatin, Detrol, Aleve FH: Sister died of ovarian cancer, mother died of unknown metastatic cancer
4
5
6 According to McNeal s model
7
8 Proximal Lissosphincter Bladder musculature Prostate Distal Lissosphincter Rhabdosphincter
9 Most common neoplasm among men Incidence: 119 per 100,000 2 nd most common cause of death due to cancer 95% of tumors are adenomcarcinomas Primarily arises from peripheral (transition zone) Increased risk: Genetic African American Dietary (High fats) Environmental Hormonal
10 Controversies Traditional screening guidelines PSA levels >10 ng/ml for men age >40 OR Digital rectal exam: Palpable rock hard nodule If any of these found they were sent for TRUS guided biopsy Unfortunately, PSA levels never correlated with a reduction in cancer mortality and potentially led to overdiagnosis and overtreatment of otherwise benign tumors New American Urologic Association guidelines as of 2009 included the following changes: 1. PSA testing offered to wellinformed patients age>40 with a life expectancy >10 years 2a. Routine bone scan is not required 2b. However, bone scans are indicated for the detection of mets following initial treatment of disease 3. CT or MRI may be considered for staging when PSA <20 ng/ml
11 15yr Recurren ce Survival Staging Findings Treatment 100% T1a Non-palpable tumor; low grade cancer <5% of prostate Observation 70-80% T1b High grade tumor; >5% prostate involved 85% T2a 1 lobe or less 60-70% T2b More than 1 lobe 20-60% T3a Unilateral Extraprostatic Extension 0-10% T3b Bilateral Extraprostatic Extension 0-10% T3c Seminal Vesicle Invasion 0-10% T4a Invades Bladder Neck or Rectum 0-10% T4b Invades Levator muscle 0-10% M+ Pelvic lymph node or distant metastases Radical Prostatectomy/ External Beam Radiation/ Brachytherapy Radical Prostatectomy/ External Beam Radiation/ Brachytherapy Radical Prostatectomy/ External Beam Radiation/ Brachytherapy Radical Prostatectomy/ External Beam Radiation/ Brachytherapy Hormonal Therapy (Orchioectomy OR LHRH/Antiandrogen) + external beam radiation Hormonal Therapy (Orchioectomy OR LHRH/Antiandrogen) + external beam radiation Hormonal Therapy (Orchioectomy OR LHRH/Antiandrogen) + external beam radiation Hormonal Therapy (Orchioectomy OR LHRH/Antiandrogen) when symptomatic; irradiation for isolated bone pain+ external beam radiation Hormonal Therapy (Orchioectomy OR LHRH/Antiandrogen) + external beam radiation
12 Trans rectal Ultrasonography Doppler TRUS Endorectal MRI Axial CT Bone Scan Antibody Imaging iopsyultrasound.html
13 Borlev et al: Most common diagnostic modality 2 Primary role is for tissue diagnosis: 12 core needle biospy Hypoechoic lesions (traditionally) Only 20% of hypoechoic lesions prove to be cancer on biopsy No t recommended for screening Patient Prep: Fleet enema 4 hrs prior to exam Antibiotic (Cephalexin) if biopsy Indications: Elevated PSA or PSA velocity Previous biopsies showing intraepithelial neoplasia (PIN) or small acinar proliferation (ASAP) Contraindications: Elderly or frail men Massively elevated PSA with abnormal DRE Turkbey et al Drawbacks: Low sensitivity and specifcity Small foci are often not visible 3
14 1. Hypoechoic lesion in the peripheral zone with illdefined borders 2. Assymetrical peripheral zone 3. Inhomogenity or focal capsular bulge 4. Pericapsular irregularity High grade malignancies: Heterogeneous Well differenianted lesions: Hypoechoic iopsyultrasound.html
15 Example 1 iopsyultrasound.html
16 Example 2 : overview Calcifications Right lobe Left Lobe Hypoechoic lesion
17 Hypoechoic lesions near the peripheral zone 11 Chronic or Acute Prostatitis Benign Prostate Hypertrophy (although it would more likely appear in the periurethral zone) Prostate carcinoma including adenocarcinoma
18 Endorectal coil Medical device used to obtain high quality images in the organs of the pelvis improves cancer detection and staging Accuracy ranges from 51% to 92% T2 weighted image is the test of choice
19 Indications: Staging of known prostate cancer Guidance for radiation implant placement Contraindications: Incompatible devices Prep NPO 6 hrs prior IM Glucagon to decrease intestinal motility Limited availability of MRI Obese pts may not fit Sensitivity to motion limits uncooperative pts Insensitive to subtle calcifications or small bony fragments
20 T2 weighted image is the test of choice Peripheral zone Low intensity signal in cancer High intensity signal in normal Central zone Low signal intensity normally Cancer is difficult to find in this area DDx of Low intensity in central zone Prostatitis Infarcts Stromal BPH Staging Factors: Direct Extension through 12 : Tumor capsule (T3a) Periprostatic fat (T3b) Neurovascular bundles (T3b) Seminal Vescicles (T3c) Metastasis to pelvic lymph nodes (M+)
21 4 T2 coronal Bladder Prostate cancer located in the Periurethral zone Urethra Prostate
22
23
24 Purpose is to exclude lymph node mestastases in high risk patients If adenopathy is detected, then CT guided biosy is encouraged Sensitivity is low and varied (30 40%) Indications: Previously detected negative bone scan Stage T3 cancers PSA >20 ng/ml Drawbacks: Poor soft tissue resolution Not widely used Not used routine for follow up Ionizing radiation Overall not helpful
25 5.
26 Given his radiologic findings in Endorectal MRI, it was omnious for recurrence Staging T3c Given that he is s/p radical prostatectomy and s/p brachytherapy, Hormonal Therapy would probably be warranted at this time
27 Nerve sparing dissection of the apical neck bladder with lymph node dissection Goals: complete removal of the prostate gland along with surrounding tissue Tumor margins as negative as possible Modalities Open approach Laparoscopy Robotic Assisted Indications: ct1b and ct2 7 T1: Non palpable tumor, high grade tumor >5% involved T2: Tumor involving 1 lobe or less ct3: controversy 6 Unilateral extraprostatic extension 7 Usually involves radiotherapy, Hill 2007 would argue in certain cases it is clinically warranted
28 Loughlin et al Urinary Incontinence Incidence: up to 69% 8 Emotionally disturbing Severe morbidity Up to 90% gain function within 24 months depending on which study
29 Patient Age Older men have thinner rhabdomyosphincter Higher BMI Pre OP ED Preo OP voiding dysnfunction Gleason score Prior TURP
30 Debates in the Urology community over what is the exact etiology of urinary incontinence after radical prostatectomy Exact Pathophysiology is debated Surgical techniques is also debated Pathophysiology Rhabdosphincter vs Lissosphincter according to Koraitim 10 Rhabdosphincter is skeletal muscle that surrounds urethra Not involved in maintaining continence Fatigues easily Lissosphincter is smooth muscle that wraps around urethra Involved in maintaining continence Tonically contracted
31 Puboprostatic Ligament sparing surgery Steiner et al 13 Advocates in order to optimize urethral length and leave the anterior support of the urethra Poore et al 14 Rapid return to continence in the puboprostatic ligament sparing group (34 vs 57 wks in the control group Deliveliotis et al 15 Found no difference in the puboprostatic ligament sparing group, bladder neck preservation or having both procedures in the length of continence recovery Seminal vescicle sparing Hauri et al 16 Pelvic nerve transverses rhabdosphincter and supplies smooth muscle (lissosphincter) Reports continence rates of 95% after 6 months in the seminal vescicle spare group versus 85% in controls
32 Given the relapse of Mr. RS does it really matter to discuss urinary incontinence? If we approach as a life of quality issue Should a different surgical approach have been taken? Should puboprostatic ligament sparing and seminal vescicle sparing techniques have been implemented? More fundamentally What might be the relative effectiveness between radical prostatectomy, brachytherapy and external beam radiation? Which approach should be attempted first? Second?
33 Prostate Cancer is a very common neoplasm among men, 2 nd deadliest Work up involves changes in PSA or palpable hard rock nodule in the prostate This is followed by TRUS that guides biopsy Hypoechoic lesion in the peripheral zone suggests cancer Hypoechoic lesion in the transition zone suggests BPH If carcinoma is present, Endorectal MRI is used for staging and surgical planning T2 hypointense signal in the peripheral zone suggests carcinoma If contraindications, CT may be used Depending on TNM staging (T1b T3a) one may opt for radical prostatectomy, brachytherapy and external beam radiation Radical prostatectomy has side effects that include urinary incontinence Causes of urinary incontinence are debated in the literature Factors: Age, BMI, pre op function, s/p TURP Koraitim proposes lissosphincter model as a way to maintain continence Different surgical techniques
34 Olga Brook, MD Gillian Lieberman, MD Maria Levantakis
35 Prostate cancer: diagnosis and staging Nigel Borley, Mark R. Feneley images.com/prostate.htm 4. Incremental Value of Multiplanar Cross Referencing for Prostate Cancer Staging with Endorectal MRI 3. Imaging techniques for prostate cancer: implications for focal therapy. Baris Turkbey, Peter A. Pinto and Peter L. Choyke 5. media 6. Radical prostatectomy for clinical T3 disease: expanding indications while optimizing cancer control and quality of life Jennifer R Hill, Samson W Fine, Jingbo Zhang and James A Eastham 7. CURRENT Diagnosis & Treatment: Surgery > Chapter 38. Urology > Tumors of the Genitourinary Tract > Carcinoma of the Prostate > Clinical Findings > Symptoms and Signs > 8. Wei JT, Dunn RL, Marcovich R et al: Prospective assessment of patient reported urinary continenceradical prostatectomy. J Urol 2000; 164: Post Prostatectomy Urinary Incontinence: A Confluence of 3 Factors Kevin R. Loughlin* and Michaella M. Prasad 10. The Male Urethral Sphincter Complex Revisited: An Anatomical Concept and its Physiological Correlate Mamdouh M. Koraitim 11. Hypoechoic Rim of Chronically Inflamed Prostate, as Seen at TRUS: Histopathologic Findings Hak Jong Lee, MD,1 Ghee Young Choe, MD,2 Chang Gyu Seong, MD,3 and Seung Hyup Kim, MD4
36 12. CURRENT Diagnosis & Treatment: Surgery > Chapter 38. Urology > Tumors of the Genitourinary Tract > Carcinoma of the Prostate > Clinical Findings > Symptoms and Signs > 13. Steiner MS: The puboprostatic ligament and the male urethral suspensory mechanism: an anatomic study. Urology 1994; 44: Poore RE, McCullough DL and Jarow JP: Puboprostatic ligament sparing improves urinary continence after radical retropubic prostatectomy. Urology 1998; 51: Deliveliotis C, Protogerou V, Alargof E et al:radical prostatectomy: bladder neck preservation and puboprostatic ligament sparing effects on continence and positive margins. Urology 2002;60: John H and Hauri D: Seminal vesicle sparing radical prostatectomy: a novel concept to restore early urinary continence. Urology 2000; 55: 820.
37
Prostate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
More informationI have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.
Prostate t Cancer MR Report Disclosure Information Vikas Kundra, M.D, Ph.D. I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a g product
More informationGUIDELINES ON PROSTATE CANCER
10 G. Aus (chairman), C. Abbou, M. Bolla, A. Heidenreich, H-P. Schmid, H. van Poppel, J. Wolff, F. Zattoni Eur Urol 2001;40:97-101 Introduction Cancer of the prostate is now recognized as one of the principal
More informationCase Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.
Case Scenario 1 3/8/13 H&P 68 YR W/M presents w/elevated PSA. Patient is a non-smoker, current alcohol use. Physical Exam: On digital rectal exam the sphincter tone is normal and there is a 1 cm nodule
More information11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.
Multi-parametric MRI of Prostate Diagnosis and Treatment Planning Temel Tirkes, M.D. Associate Professor of Radiology Director, Genitourinary Radiology Indiana University School of Medicine Department
More informationCase Discussions: Prostate Cancer
Case Discussions: Prostate Cancer Andrew J. Stephenson, MD FRCSC FACS Chief, Urologic Oncology Glickman Urological and Kidney Institute Cleveland Clinic Elevated PSA 1 54 yo, healthy male, family Hx of
More informationDefinition Prostate cancer
Prostate cancer 61 Definition Prostate cancer is a malignant neoplasm that arises from the prostate gland and the most common form of cancer in men. localized prostate cancer is curable by surgery or radiation
More informationA schematic of the rectal probe in contact with the prostate is show in this diagram.
Hello. My name is William Osai. I am a nurse practitioner in the GU Medical Oncology Department at The University of Texas MD Anderson Cancer Center in Houston. Today s presentation is Part 2 of the Overview
More informationADENOCARCINOMA OF THE PROSTATE
Ref : ADENOCARCINOMA OF THE PROSTATE Div. of Urology, Dept. Surgery Medical Faculty, University of Sumatera Utara Clinical Manual of Urology, (Philip M. Hanno et al eds), McGraw-Hill Int ed, 3 rd ed, 2001
More informationProstate MRI. Overview. Introduction 2/20/2015. Prostate cancer is most frequently diagnosed noncutaneous cancer in males (25%)
Prostate MRI John Bell, MD Introduction Prostate Cancer Screening Staging Anatomy Prostate MRI overview Functional MRI Multiparametric Approach Indications Example Cases Overview Introduction Prostate
More informationWhen to worry, when to test?
Focus on CME at the University of Calgary Prostate Cancer: When to worry, when to test? Bryan J. Donnelly, MSc, MCh, FRCSI, FRCSC Presented at a Canadian College of Family Practitioner s conference (October
More informationProstate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018
Prostate cancer staging and datasets: The Nitty-Gritty What determines our pathological reports? Dan Berney Maastricht 2018 Biopsy reporting. How not to do it. The TNM 8 th edition. Changes good and bad
More informationPROSTATE MRI. Dr. Margaret Gallegos Radiologist Santa Fe Imaging
PROSTATE MRI Dr. Margaret Gallegos Radiologist Santa Fe Imaging Topics of today s talk How does prostate MRI work? Definition of multiparametric (mp) MRI Anatomy of prostate gland and MRI imaging Role
More informationQ&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1
Collecting Cancer Data: Prostate NAACCR 2010-2011 Webinar Series May 5, 2011 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview NAACCR 2010-2011 Webinar Series 1
More informationGUIDELINEs ON PROSTATE CANCER
GUIDELINEs ON PROSTATE CANCER (Text update March 2005: an update is foreseen for publication in 2010. Readers are kindly advised to consult the 2009 full text print of the PCa guidelines for the most recent
More informationEssentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis
73. Urinary Bladder and Male Pelvis Urinary bladder carcinoma is best locally staged with MRI. It is important however to note that a thickened wall (> 5 mm) is a non-specific finding seen in an underfilled
More informationProstate Cancer Case Study 1. Medical Student Case-Based Learning
Prostate Cancer Case Study 1 Medical Student Case-Based Learning The Case of Mr. Powers Prostatic Nodule The effervescent Mr. Powers is found by his primary care provider to have a prostatic nodule. You
More informationda Vinci Prostatectomy
da Vinci Prostatectomy Justin T. Lee MD Director of Robotic Surgery Urology Associates of North Texas (UANT) USMD Prostate Cancer Center (www.usmdpcc.com) Prostate Cancer Facts Prostate cancer Leading
More informationCollecting Cancer Data: Prostate Q&A. Overview. NAACCR Webinar Series June 11, 2009
Collecting Cancer Data: Prostate NAACCR 2008-2009 Webinar Series June 11, 2009 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview 2008-2009 NAACCR Webinar Series
More informationChapter 18: Glossary
Chapter 18: Glossary Sutter Health Cancer Service Line: Prostate Committee Advanced cancer: When the cancer has spread to other parts of the body (including lymph nodes, bones, or other organs) and is
More informationProstate Overview Quiz
Prostate Overview Quiz 1. The path report reads: Gleason 3 + 4 = 7. The Gleason s score is a. 3 b. 4 c. 7 d. None of the above 2. The path report reads: Moderately differentiated adenocarcinoma of the
More informationHypoechoic Rim of Chronically Inflamed Prostate, as Seen at TRUS: Histopathologic Findings
Hypoechoic Rim of Chronically Inflamed Prostate, as Seen at TRUS: Histopathologic Findings Hak Jong Lee, MD 1 Ghee Young Choe, MD 2 Chang Gyu Seong, MD 3 Seung Hyup Kim, MD 4 Index terms: Prostate Prostate,
More informationDepartment of Urology, Cochin hospital Paris Descartes University
Technical advances in the treatment of localized prostate cancer Pr Michaël Peyromaure Department of Urology, Cochin hospital Paris Descartes University Introduction Curative treatments of localized prostate
More informationSEER Summary Stage Still Here!
SEER Summary Stage Still Here! CCRA NORTHERN REGION STAGING SYMPOSIUM SEPTEMBER 20, 2017 SEER Summary Stage Timeframe: includes all information available through completion of surgery(ies) in the first
More information20 Prostate Cancer Dan Ash
20 Prostate Cancer Dan Ash 1 Introduction Prostate cancer is a disease of ageing men for which the aetiology remains unknown. The incidence rises up to 30 to 40% in men over 80. The symptoms of localised
More informationProstate Cancer. David Wilkinson MD Gulfshore Urology
Prostate Cancer David Wilkinson MD Gulfshore Urology What is the Prostate? Male Sexual Gland Adds nutrients and fluids for sperm This fluid is added to sperm during ejaculation Urethra (urine channel)
More informationWhat Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen).
What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen). It is a very common cancer in men; some cancers grow very slowly,
More informationS Crouzet, O Rouvière, JY Chapelon, F Mege, X martin, A Gelet
S Crouzet, O Rouvière, JY Chapelon, F Mege, X martin, A Gelet Why HIFU? Efficacy demonstrated Real time control of the target Early control of the necrosis area is possible with MRI or TRUS using contrast
More informationThe importance of maximal restoration of peri-prostatic support
Providing the best evidence for each surgical option in organ confined prostate cancer The importance of maximal restoration of peri-prostatic support A. Mottrie ORSI-Academy Melle Belgium OLV Hospital
More informationBrief History. Identification : Past History : HTN without regular treatment.
Brief History Identification : Name : 陳 x - Admission : 94/10/06 Gender : male Age : 75 y/o Chief Complaint : Urinary difficulty for months. Past History : HTN without regular treatment. Brief History
More informationMultiparametric MR Imaging of the Prostate after Treatment of Prostate Cancer
Multiparametric MR Imaging of the Prostate after Treatment of Prostate Cancer RadioGraphics 2018; 38:437 449 Pritesh Patel, MD Melvy S. Mathew, MD Igor Trilisky, MD Aytekin Oto, MD, MBA Jeffrey S. Klein,
More informationMUSCLE - INVASIVE AND METASTATIC BLADDER CANCER
10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg
More informationChapter 2. Understanding My Diagnosis
Chapter 2. Understanding My Diagnosis With contributions from Nancy L. Brown, Ph.D.,Palo Alto Medical Foundation Research Institute; and Patrick Swift, M.D., Alta Bates Comprehensive Cancer Program o Facts
More informationProstatectomy as salvage therapy. Cases. Paul Cathcart - Guy s & St Thomas NHS Trust, London
Prostatectomy as salvage therapy Cases Paul Cathcart - Guy s & St Thomas NHS Trust, London Attributes of brachytherapy appeal to young men who place high utility on genitourinary function At risk of
More informationDiagnosis of prostate cancer
Diagnosis of prostate cancer Epidemiology Prostate cancer (PC) is the most common cancer in men and the 2 nd cause of cancer death in the developed world. Incidence with age, reaching 80% at age 80 (at
More informationCollaborative Staging
Slide 1 Collaborative Staging Site-Specific Instructions Prostate 1 In this presentation, we are going to take a closer look at the collaborative staging data items for the prostate primary site. Because
More informationS1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles
Prostate Cancer Histopathology Reporting Proforma (Radical Prostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth Sex Male
More informationS1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES
Prostate Cancer Histopathology Reporting Proforma (Radical Prostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth Indigenous
More informationCase #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).
SOLID TUMORS WORKSHOP Cases for review Prostate Cancer Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ). January 2009 PSA 4.4, 20% free; August 2009 PSA 5.2; Sept 2009
More informationNeoplasms of the Prostate and Bladder
Neoplasms of the Prostate and Bladder 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 CDC & Florida DOH Attribution
More informationComparative Analysis Research of Robotic Assisted Laparoscopic Prostatectomy
Comparative Analysis Research of Robotic Assisted Laparoscopic Prostatectomy By: Jonathan Barlaan; Huy Nguyen Mentor: Julio Powsang, MD Reader: Richard Wilder, MD May 2, 211 Abstract Introduction: The
More informationPatient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for
High Intensity Focused Ultrasound for Prostate Tissue Ablation Patient Information CAUTION: Federal law restricts this device to sell by or on the order of a physician CONTENT Introduction... 3 The prostate...
More informationDiagnosis, pathology and prognosis including variant pathology
PROSTATE CANCER Diagnosis, pathology and prognosis including variant pathology No Conflict of Interest Universitat Autónoma de Barcelona F.Algaba Section of Pathology PROSTATE CANCER Diagnosis, pathology
More informationAJCC Cancer Staging 8 th Edition. Prostate Chapter 58. Executive Committee, AJCC. Professor and Director, Duke Prostate Center
AJCC Cancer Staging 8 th Edition Prostate Chapter 58 Judd W Moul, MD, FACS Executive Committee, AJCC Professor and Director, Duke Prostate Center Duke University Durham, North Carolina Validating science.
More informationAccuracy of post-radiotherapy biopsy before salvage radical prostatectomy
Accuracy of post-radiotherapy biopsy before salvage radical prostatectomy Joshua J. Meeks, Marc Walker*, Melanie Bernstein, Matthew Kent and James A. Eastham Urology Service, Department of Surgery and
More informationProstate Cancer Incidence
Prostate Cancer: Prevention, Screening and Treatment Philip Kantoff MD Dana-Farber Cancer Institute Professor of fmedicine i Harvard Medical School Prostate Cancer Incidence # of patients 350,000 New Cases
More informationProstate Cancer Local or distant recurrence?
Prostate Cancer Local or distant recurrence? Diagnostic flowchart Vanessa Vilas Boas Urologist VFX Hospital FEBU PSA - only recurrence PSA recurrence: 27-53% of all patients undergoing treatment with curative
More informationDisclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None
What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department
More informationProcedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy
Prostate Gland Protocol applies to invasive carcinomas of the prostate gland. Protocol web posting date: July 2006 Protocol effective date: April 2007 Based on AJCC/UICC TNM, 6 th edition Procedures Needle
More informationCase Scenario 1: Breast
Case Scenario 1: Breast A 63 year old white female presents with a large mass in her left breast. 4/15/13 Mammogram/US: 1. Left breast mammographic and sonographic at 3:00 measuring 7.1 cm highly suggestive
More informationda Vinci Prostatectomy My Greek personal experience
da Vinci Prostatectomy My Greek personal experience Vassilis Poulakis MD, PhD, FEBU Ass. Prof. of Urology Director of Urologic Clinic Doctors Hospital Athens Laparoscopy - golden standard in Urology -
More informationLocalized Prostate Cancer and Its Treatment- A Patient Guide
Your Health Matters Localized Prostate Cancer and Its Treatment- A Patient Guide Department of Urology UCSF Helen Diller Family Comprehensive Cancer Center University of California. San Francisco 550 16th
More informationNewer Aspects of Prostate Cancer Underwriting
Newer Aspects of Prostate Cancer Underwriting Presented By: Jack Swanson, M.D. Keith Hoffman, NFP Moments Made Possible Objectives To review and discuss Conflicting messages about PSA testing Cautions
More informationProstate Cancer: Imaging in Diagnosis and Treatment
March 2002 Prostate Cancer: Imaging in Diagnosis and Treatment David Sher, Harvard Medical School III Introduction The prostate gland is a walnut-sized exocrine gland that surrounds the urethra between
More informationBoot Camp Case Scenarios
Boot Camp Case Scenarios Case Scenario 1 Patient is a 69-year-old white female. She presents with dyspnea on exertion, cough, and right rib pain. Patient is a smoker. 9/21/12 CT Chest FINDINGS: There is
More information1. Benign Prostate Hyperplexia (BPH) 2. Prostate Cancer (PCa)
Objectives: Our first segment focused in the anatomy and functions of the prostate gland, to get a clear understanding of the male Genito-Urinary System. Now, we will explore two of the main problems associated
More informationProstate Cancer: 2010 Guidelines Update
Prostate Cancer: 2010 Guidelines Update James L. Mohler, MD Chair, NCCN Prostate Cancer Panel Associate Director for Translational Research, Professor and Chair, Department of Urology, Roswell Park Cancer
More informationTOPICS FOR DISCUSSION
INTERNATIONAL SOCIETY OF UROLOGIC PATHOLOGY PATHOLOGIC STAGING OF SELECT UROLOGIC MALIGNANCIES Mahul B. Amin, MD Professor and Chairman Pathology and Laboratory Medicine Cedars-Sinai Medical Center Los
More informationProstate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017
Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017 Dr Puay Hoon Tan Division of Pathology Singapore General Hospital Prostate cancer (acinar adenocarcinoma) Invasive carcinoma composed
More informationINTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein
INTRADUCTAL LESIONS OF THE PROSTATE Jonathan I. Epstein Topics Prostatic intraepithelial neoplasia (PIN) Intraductal adenocarcinoma (IDC-P) Intraductal urothelial carcinoma Ductal adenocarcinoma High Prostatic
More informationProstate MRI: Who needs it?
Prostate MRI: Who needs it? Fergus Coakley MD, Professor of Radiology and Urology, Vice Chair for Clinical Services, Chief of Abdominal Imaging, UCSF Abdominal Imaging Magnetic Resonance Science Center
More informationMetachronous anterior urethral metastasis of prostatic ductal adenocarcinoma
http://dx.doi.org/10.7180/kmj.2016.31.1.66 KMJ Case Report Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma Jeong Hyun Oh 1, Taek Sang Kim 1, Hyun Yul Rhew 1, Bong Kwon Chun
More informationClinical Case Conference
Clinical Case Conference Intermediate-risk prostate cancer 08/06/2014 Long Pham Clinical Case 64 yo man was found to have elevated PSA of 8.65. TRUS-biopies were negative. Surveillance PSA was 7.2 in 3
More informationIntussusception of the bladder neck does not promote early restoration to urinary continence after non-nervesparing radical retropubi c prostatectomy
Blackwell Science, LtdOxford, UKIJUInternational Journal of Urology0919-81722004 Blackwell Publishing Asia Pty LtdMarch 2004123275279Original ArticleIntussusception of the bladder neck and early continencei
More informationClinical Prostate Cancer Imaging
Clinical Prostate Cancer Imaging Steven C. Eberhardt, MD Professor and Vice Chair of Clinical Operations Chief of Abdominal and Oncology Radiology UNM Health Sciences Center UNM Comprehensive Cancer Center
More informationOverview. What is Cancer? Prostate Cancer 3/2/2014. Davis A Romney, MD Ironwood Cancer and Research Centers Feb 18, 2014
Prostate Cancer Davis A Romney, MD Ironwood Cancer and Research Centers Feb 18, 2014 Overview Start with the basics: Definition of cancer Most common cancers in men Prostate, lung, and colon cancers Cancer
More informationStephen McManus, MD David Levi, MD
Stephen McManus, MD David Levi, MD Prostate MRI Indications INITIAL DETECTION, STAGING, RECURRENT TUMOR LOCALIZATION, RADIATION THERAPY PLANNING INITIAL DETECTION Clinically suspected prostate cancer before
More informationUtility of Prostate MRI. John R. Leyendecker, MD
Utility of Prostate MRI John R. Leyendecker, MD Professor of Radiology and Urology Executive Vice Chair of Clinical Operations Section Head, Abdominal Imaging Wake Forest University School of Medicine;
More informationElevated PSA. Dr.Nesaretnam Barr Kumarakulasinghe Associate Consultant Medical Oncology National University Cancer Institute, Singapore 9 th July 2017
Elevated PSA Dr.Nesaretnam Barr Kumarakulasinghe Associate Consultant Medical Oncology National University Cancer Institute, Singapore 9 th July 2017 Issues we will cover today.. The measurement of PSA,
More informationImproved Detection of Clinically Significant Prostate Cancer Using a Structured Prostate Imaging Reporting Data System (PI-RADS) Template
Improved Detection of Clinically Significant Prostate Cancer Using a Structured Prostate Imaging Reporting Data System (PI-RADS) Template Abstract #17-130 ACR Annual Meeting 2017 Presenting Author: Whitney
More informationProstate Cancer Imaging :What the Urologist Needs to Know
Prostate Cancer Imaging :What the Urologist Needs to Know Poster No.: C-2513 Congress: ECR 2015 Type: Educational Exhibit Authors: C. Aimeur, M. tabouche, A. habouchi, A. Habba, B. Mansouri; Algiers/DZ
More informationWhen PSA fails. Urology Grand Rounds Alexandra Perks. Rising PSA after Radical Prostatectomy
When PSA fails Urology Grand Rounds Alexandra Perks Rising PSA after Radical Prostatectomy Issues Natural History Local vs Metastatic Treatment options 1 10 000 men / year in Canada 4000 RRP 15-year PSA
More informationTrends in Prostate Cancer Bob Weir AVP Underwriting Research Canada Life Reinsurance
Trends in Prostate Cancer Bob Weir AVP Underwriting Research Canada Life Reinsurance Metropolitan Underwriting Discussion Group Annual Meeting January 30, 2017 Prostate Cancer is Common Rudy Giuliani Dx
More informationRadiation Therapy for Prostate Cancer. Resident Dept of Urology General Surgery Grand Round November 24, 2008
Radiation Therapy for Prostate Cancer Amy Hou,, MD Resident Dept of Urology General Surgery Grand Round November 24, 2008 External Beam Radiation Advances Improving Therapy Generation of linear accelerators
More informationIf you have aggressive cancer, you would want treatment in time for a cure.
Prostate cancer: PSA screening, biopsy, new technologies The treatment/cure should never be worse than the disease. If you have aggressive cancer, you would want treatment in time for a cure. What is PSA?
More informationProstate Cancer: Screening, Treatment, and Survivorship
Prostate Cancer: Screening, Treatment, and Survivorship Timothy C. Brand, MD, FACS LTC(P), MC, USA Urology Residency Director Associate Professor of Surgery, USUHS Madigan Army Medical Center No Disclosures
More informationFive Views of Transitional Cell Carcinoma: One Man s Journey
September 2006 Five Views of Transitional Cell Carcinoma: One Man s Journey Amsalu Dabela, Harvard Medical School III Outline Overview: Renal Anatomy Our Patient s Story Diagnostic Imaging Studies Appearance
More informationNICE BULLETIN Diagnosis & treatment of prostate cancer
Diagnosis & treatment of prostate cancer NICE provided the content for this booklet which is independent of any company or product advertised Diagnosis and treatment of prostate cancer Introduction In
More informationGeneral information about prostate cancer
Prostate Cancer General information about prostate cancer Key points Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate. Signs of prostate cancer include
More informationIntroduction. Growths in the prostate can be benign (not cancer) or malignant (cancer).
This information was taken from urologyhealth.org. Feel free to explore their website to learn more. Another trusted website with good information is the national comprehensive cancer network (nccn.org).
More informationTHE UROLOGY GROUP
THE UROLOGY GROUP www.urologygroupvirginia.com 1860 Town Center Drive Suite 150/160 Reston, VA 20190 703-480-0220 19415 Deerfield Avenue Suite 112 Leesburg, VA 20176 703-724-1195 224-D Cornwall Street,
More informationAbout the authors Dr S. Larry Goldenberg Dr Tom Pickles Dr Kim N. Chi
Authors S. Larry Goldenberg, CM, OBC, MD, FRCSC, FCAHS Professor and Head, University of British Columbia Department of Urologic Sciences, Stephen A. Jarislowski Chair in Urologic Sciences at Vancouver
More informationPROSTATE CANCER: A Primer of Diagnosis and Treatment. Jay C. Lee, MD, FRCSC Clinical Associate Professor University of Calgary
PROSTATE CANCER: A Primer of Diagnosis and Treatment Jay C. Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document
More informationMagnetic resonance imaging predictors of extracapsular extension of prostate cancer: Do they accurately reflect pt3 staging?
Magnetic resonance imaging predictors of extracapsular extension of prostate cancer: Do they accurately reflect pt3 staging? Poster No.: C-1399 Congress: ECR 2010 Type: Scientific Exhibit Topic: Genitourinary
More informationPSA. HMCK, p63, Racemase. HMCK, p63, Racemase
Case 1 67 year old male presented with gross hematuria H/o acute prostatitis & BPH Urethroscopy: small, polypoid growth with a broad base emanating from the left side of the verumontanum Serum PSA :7 ng/ml
More informationDavid Gillatt Bristol Urological Institute. David Gillatt Bristol UK
David Gillatt Bristol Urological Institute David Gillatt Bristol UK Prostate Problems The prostate grows with age - >80% men over 60 have benign enlargement As it grows it can obstruct the flow of urine
More informationProtocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland
Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland Version: Protocol Posting Date: June 2017 Includes ptnm requirements from the 8 th Edition, AJCC Staging Manual
More informationProstate MRI for local staging and surgical planning in prostate cancer
Prostate MRI for local staging and surgical planning in prostate cancer 15th Annual Floyd A. Fried Advances in Urology Symposium June 23, 2017 Ray Tan, MD, MSHPM Assistant Professor Disclosures None Objectives
More informationLocalized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA
Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA ESMO Cape Town 14 Feb 2018 Disclosures Advisory boards/lecturer/consultant-
More informationGenitourinary Neoplasms Updated for 2012 Requirements and CSv02.04
Presentation Outline Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 X:\FCDS_PUB\wwwroot\downloads\Teleconfere nces\2013 FCDS Educational Webcast Series February 28, 2013 General Information
More informationGenitourinary Neoplasms Updated for 2012 Requirements and CSv02.04
Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 X:\FCDS_PUB\wwwroot\downloads\Teleconfere nces\2013 FCDS Educational Webcast Series February 28, 2013 1 Steven Peace, BS, CTR Susan Smith
More informationProstate Cancer. Diagnosis and Treatment. September 2016 Saskatchewan Prostate Assessment Pathway
Prostate Cancer Diagnosis and Treatment September 016 Saskatchewan Prostate Assessment Pathway Table of Contents Introduction... Patient and Coach Information... Nurse Navigators... About Your Prostate...
More informationThe Selenium and Vitamin E Prevention Trial
The largest-ever-prostate cancer prevention trial is now underway. The study will include a total of 32,400 men and is sponsored by the National Cancer Institute and a network of researchers known as the
More informationMEDICAL POLICY Genetic and Protein Biomarkers for Diagnosis and Risk Assessment of
POLICY: PG0367 ORIGINAL EFFECTIVE: 08/26/16 LAST REVIEW: 09/27/18 MEDICAL POLICY Genetic and Protein Biomarkers for Diagnosis and Risk Assessment of Prostate Cancer GUIDELINES This policy does not certify
More informationGenitourinary. Presentation Outline. Genitourinary System 12/14/2011. FCDS 2011 Educational Webcast Series December 15, 2011
Genitourinary FCDS 2011 Educational Webcast Series December 15, 2011 1 Susan Smith Pierce, CTR Gema Midence, MBA, CTR Steven Peace, BS, CTR Presentation Outline Overview including Anatomy and General Information
More informationMODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT
MODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT KEYWORDS: Prostate cancer, PSA, Screening, Radical Prostatectomy LEARNING OBJECTIVES At the end of this clerkship, the medical student will be able to:
More informationJMSCR Vol 05 Issue 06 Page June 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i6.29 MRI in Clinically Suspected Uterine and
More informationIn autopsy, 70% of men >80yr have occult prostate ca
Prostate Cancer UpToDate: Introduction: Risk Factors: Biology: Symptoms: Diagnosis: Two randomized trials showed survival benefit of adding docetaxol to ADT in fit man with very high localized disease
More informationProstate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144
Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144 Objectives: Detection of prostate cancer the need for better imaging What
More information